Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis.
Conclusion: Evocalcet was effective and safe in regulating the levels of serum intact PTH, calcium, and phosphate in patients with secondary hyperparathyroidism undergoing hemodialysis, irrespective of dialysate calcium concentration.
PMID: 32494184 [PubMed]
Source: International Journal of Nephrology and Renovascular Disease - Category: Urology & Nephrology Tags: Int J Nephrol Renovasc Dis Source Type: research
More News: Calcium | Dialysis | Drugs & Pharmacology | Gastroenterology | Hemodialysis | Hormones | Hyperparathyroidism | Japan Health | Phosphorus | Sensipar | Study | Urology & Nephrology